PD-L1 Protein Drives Aggressive Growth and Recurrence in Jaw Tumors
New research reveals how PD-L1 protein fuels ameloblastoma tumor growth and recurrence, opening doors for targeted therapy approaches.
688 articles in this topic
New research reveals how PD-L1 protein fuels ameloblastoma tumor growth and recurrence, opening doors for targeted therapy approaches.
Researchers develop targeted drug that degrades FTO protein, disrupting ribosome production and protein synthesis in leukemia cells.
Researchers identified three distinct nasopharyngeal cancer subtypes with different treatment vulnerabilities using comprehensive molecular profiling.
Early PSMA upregulation after enzalutamide predicts shorter survival, but adding Lu-177-PSMA-617 improves outcomes in resistant prostate cancer.
New research explores how prenatal DNA screening could identify cancer in pregnant women, potentially saving lives through early detection.
Editorial expression of concern raised for influential 1999 research on creating human tumor cells with defined genetic elements.
Researchers identify how HER2 expression patterns reveal functional changes in breast cancer cells circulating through blood.
Breakthrough platform mimics natural virus environment, exposing how antibodies truly attack HIV and Ebola for smarter vaccine design.
New targeted therapy offers hope for patients with specific genetic mutations in non-small cell lung cancer.
New JAMA patient guide covers endometrial cancer warning signs, diagnostic methods, and treatment approaches in plain language.
New JAMA review reveals alarming trends in endometrial cancer: rising mortality rates and increasing cases in women under 40.
Relacorilant plus nab-paclitaxel significantly improved overall survival compared to standard treatment in advanced ovarian cancer patients.